Medical laboratories

Ended Awarded Last action

Contract number
W90VN622F5015
Awardee
Awarding agency
Obligated
$1,759

Award facts

Contract value 1% obligated
  • $1,758.86 Current, with exercised options
  • $150,000.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Funding agency
Pacific Air Forces Air Force, Department of Defense
NAICS code
621511 Medical Laboratories
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
South Korea

Award details come from SAM.gov/FPDS.

About this award

This is a firm-fixed-price contract awarded by the Pacific Air Forces (PACAF), a major component command of the U.S. Air Force, to Seoul Clinical Laboratories, a for-profit medical laboratory services provider located in South Korea. The $150,000 contract is for the provision of a wide range of medical laboratory services, including COVID-19 testing, general blood work, and pathology testing, to support U.S. military healthcare operations in the region.

The contract is structured as a blanket purchase agreement (BPA) call, allowing PACAF to efficiently procure Seoul Clinical Laboratories' services as needed to meet the medical testing requirements of U.S. personnel stationed in South Korea. This contract is part of a larger $250,000 multiple-award BPA the company holds with PACAF for pathology testing services through February 2026. Seoul Clinical Laboratories has also received numerous task orders and delivery orders under its other indefinite delivery vehicle contracts with the Department of Defense, including an $11.3 million single-award contract with the Army Medical Command for COVID-19 testing services. The company has a strong track record of supporting U.S. military healthcare needs in South Korea and serves as a subcontractor to prime contractor ABT Global LLC.

Quick answers

Who was awarded contract W90VN622F5015?

W90VN622F5015 was awarded to Seoul Clinical Laboratories by RCO Osan 411th CSB (Expeditionary Contracting Command) on December 1, 2021.

How much is contract W90VN622F5015 worth?

The government has obligated $1,759 on W90VN622F5015. Its potential value, with all options, is $150,000.

Which agency awarded contract W90VN622F5015?

RCO Osan 411th CSB (Expeditionary Contracting Command) awarded W90VN622F5015, with funding from Pacific Air Forces (Air Force).

Is contract W90VN622F5015 an order under another contract?

Yes. W90VN622F5015 is a BPA call under W90VN621A0006, a blanket purchase agreement.

Was contract W90VN622F5015 competed?

The extent of competition for W90VN622F5015 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award